• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以单核细胞增生李斯特菌作为活疫苗载体诱导针对1型人类免疫缺陷病毒Gag蛋白的细胞介导免疫反应。

Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector.

作者信息

Frankel F R, Hegde S, Lieberman J, Paterson Y

机构信息

Department of Microbiology, University of Pennsylvania, School of Medicine, Philadelphia 19104, USA.

出版信息

J Immunol. 1995 Nov 15;155(10):4775-82.

PMID:7594479
Abstract

Cytolytic T cells, acting through cytokines or by direct lysis of infected target cells, have been shown to play a significant role in the control of viral infections and may be responsible for the prolonged asymptomatic phase following infection by HIV. Accordingly, methods that can generate strong cell-mediated immune responses may be useful in the development of prophylactic and therapeutic vaccines against HIV. Listeria monocytogenes is a Gram-positive intracellular microorganism that elicits strong cell-mediated immune responses against its own secreted proteins following infection. In this study we have modified the chromosome of L. monocytogenes so that it stably expresses and secretes the p55 HIV gag gene product and examined the cell-mediated immune response of BALB/c mice to infection with this recombinant organism. Infected animals were found to mount a specific, strong, long-lasting CD8+ cytolytic T cell response against a predominant epitope contained within the p24 fragment of the HIV Gag protein. This epitope previously has been shown to be recognized by CTLs obtained from some HIV-infected humans. Our results suggest that chromosomally modified strains of L. monocytogenes may provide valuable vaccine vectors for use against HIV.

摘要

细胞溶解性T细胞可通过细胞因子作用或直接裂解被感染的靶细胞,在控制病毒感染中发挥重要作用,可能是导致HIV感染后出现长期无症状期的原因。因此,能够产生强烈细胞介导免疫反应的方法,可能有助于开发针对HIV的预防性和治疗性疫苗。单核细胞增生李斯特菌是一种革兰氏阳性细胞内微生物,感染后会引发针对其自身分泌蛋白的强烈细胞介导免疫反应。在本研究中,我们对单核细胞增生李斯特菌的染色体进行了修饰,使其稳定表达并分泌p55 HIV gag基因产物,并检测了BALB/c小鼠对这种重组生物体感染的细胞介导免疫反应。发现受感染动物对HIV Gag蛋白p24片段中包含的主要表位产生了特异性、强烈且持久的CD8 + 细胞溶解性T细胞反应。此前已证明该表位可被一些HIV感染人类的细胞毒性T淋巴细胞识别。我们的结果表明,经染色体修饰的单核细胞增生李斯特菌菌株可能为抗HIV疫苗载体提供有价值的选择。

相似文献

1
Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector.以单核细胞增生李斯特菌作为活疫苗载体诱导针对1型人类免疫缺陷病毒Gag蛋白的细胞介导免疫反应。
J Immunol. 1995 Nov 15;155(10):4775-82.
2
Th1 T cell responses to HIV-1 Gag protein delivered by a Listeria monocytogenes vaccine are similar to those induced by endogenous listerial antigens.由单核细胞增生李斯特菌疫苗递送的HIV-1 Gag蛋白引发的Th1 T细胞反应,与内源性李斯特菌抗原所诱导的反应相似。
J Immunol. 1999 Aug 1;163(3):1449-56.
3
Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.对致病性单核细胞增生李斯特菌的既有免疫力并不妨碍新型重组单核细胞增生李斯特菌疫苗诱导针对猫免疫缺陷病毒的免疫反应。
Vaccine. 2005 Feb 10;23(12):1479-90. doi: 10.1016/j.vaccine.2004.09.033.
4
Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.利用嵌合gag-env病毒样颗粒开发艾滋病毒/艾滋病疫苗。
Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047.
5
Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.单核细胞增生李斯特菌及经基因工程改造以表达HIV抗原的超减毒李斯特菌菌株诱导人类免疫缺陷病毒(HIV)特异性CD8 T细胞应答。
J Virol. 2000 Nov;74(21):9987-93. doi: 10.1128/jvi.74.21.9987-9993.2000.
6
Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.一种表达高免疫原性Gag p17/p24和Pol p51抗原的G/P-92融合蛋白增强了对1型人类免疫缺陷病毒Gag和Pol的细胞免疫和体液免疫反应。
J Hum Virol. 2001 Nov-Dec;4(6):306-16.
7
Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.嵌合型HIV-1病毒样颗粒在体内诱导MHC I类限制性、CD8阳性细胞毒性T细胞反应:对HIV疫苗研发的启示
Behring Inst Mitt. 1994 Dec(95):23-34.
8
Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.多肽大小和细胞内分选对小鼠模型中DNA疫苗诱导表位特异性CTL反应的影响。
Vaccine. 2004 Apr 16;22(13-14):1732-43. doi: 10.1016/j.vaccine.2004.01.035.
9
Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.基于表达中国HIV-1 B亚型gag基因的DNA、腺病毒和仙台病毒载体的初免-加强-加强策略诱导的强效特异性免疫反应。
Vaccine. 2008 Nov 11;26(48):6124-31. doi: 10.1016/j.vaccine.2008.09.017. Epub 2008 Sep 22.
10
Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.基于HIV-1 p17的合成肽AT20-KLH免疫原性的临床前研究。
Biopolymers. 2004;76(4):334-43. doi: 10.1002/bip.20130.

引用本文的文献

1
Bacterial Spore-Based Delivery System: 20 Years of a Versatile Approach for Innovative Vaccines.细菌孢子为基础的传递系统:20 年以来一种用于新型疫苗的多用途方法。
Biomolecules. 2023 Jun 6;13(6):947. doi: 10.3390/biom13060947.
2
Safety of a Novel -Based Vaccine Vector Expressing NcSAG1 ( Surface Antigen 1).新型基于疫苗载体的 NcSAG1(表面抗原 1)表达的安全性。
Front Cell Infect Microbiol. 2021 Aug 25;11:675219. doi: 10.3389/fcimb.2021.675219. eCollection 2021.
3
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against in Mice.
基于MTBVAC的结核病-艾滋病疫苗安全,可引发艾滋病病毒特异性T细胞反应,并在小鼠中提供保护。
Mol Ther Methods Clin Dev. 2019 Feb 7;13:253-264. doi: 10.1016/j.omtm.2019.01.014. eCollection 2019 Jun 14.
4
A Lactic Acid Bacteria (LAB)-Based Vaccine Candidate for Human Norovirus.基于乳酸菌的人类诺如病毒疫苗候选物。
Viruses. 2019 Mar 2;11(3):213. doi: 10.3390/v11030213.
5
Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus.减毒单核细胞增生李斯特菌载体可克服HIV感染期间的抑制性血浆因子,刺激髓样树突状细胞,促进适应性免疫和潜伏病毒的重新激活。
AIDS Res Hum Retroviruses. 2015 Jan;31(1):127-36. doi: 10.1089/AID.2014.0138.
6
Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.减毒单核细胞增生李斯特菌:肿瘤免疫治疗未来强大且通用的载体。
Front Cell Infect Microbiol. 2014 May 12;4:51. doi: 10.3389/fcimb.2014.00051. eCollection 2014.
7
Attenuated Listeria monocytogenes as a cancer vaccine vector for the delivery of CD24, a biomarker for hepatic cancer stem cells.减毒单核细胞增生李斯特菌作为一种癌症疫苗载体,用于递送肝癌干细胞的生物标志物CD24。
Cell Mol Immunol. 2014 Mar;11(2):184-96. doi: 10.1038/cmi.2013.64. Epub 2014 Feb 3.
8
Attenuated Listeria monocytogenes vaccine vectors expressing influenza A nucleoprotein: preclinical evaluation and oral inoculation of volunteers.表达甲型流感核蛋白的减毒李斯特菌疫苗载体:临床前评估和志愿者口服接种。
Microbiol Immunol. 2011 May;55(5):304-17. doi: 10.1111/j.1348-0421.2011.00322.x.
9
A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedly.一种表达 SIV Gag 的减毒李斯特菌活疫苗载体在猕猴中安全且具有免疫原性,并可重复给药。
Vaccine. 2011 Jan 10;29(3):476-86. doi: 10.1016/j.vaccine.2010.10.072. Epub 2010 Nov 9.
10
Stable integration vector for nutrient broth-based selection of attenuated Listeria monocytogenes strains with recombinant antigen expression.用于基于营养肉汤选择具有重组抗原表达的减毒单核细胞增生李斯特菌菌株的稳定整合载体。
Clin Vaccine Immunol. 2008 Sep;15(9):1414-9. doi: 10.1128/CVI.00208-08. Epub 2008 Jul 23.